Scientific Center for Anti-infectious Drugs, Kazakhstan
3 clinical trials · Sponsor
◉ Watch Scientific Center for Anti-infectious Drugs, Kazakhstan
| Record | Firm | Date |
|---|---|---|
| "Efesovir" (FS-1) for COVID-19, Phase 2 (NCT05060705) | Scientific Center for Anti-infectious Drugs, Kazakhstan | 2025-12-01 |
| PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers (NCT04174937) | Scientific Center for Anti-infectious Drugs, Kazakhstan | 2016-06-17 |
| FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis (NCT02607449) | Scientific Center for Anti-infectious Drugs, Kazakhstan | 2013-12-01 |
Track Scientific Center for Anti-infectious Drugs, Kazakhstan automatically
Every clearance here is in the API, with alerts when new ones post.